Pharmacological effect of sodium-glucose cotransporter 2 inhibitors in reducing the incidence of nephrolithiasis

Abstract

Nephrolithiasis is one of the common diseases without effective treatment, the incidence of which has increased in the world in recent decades. Sodium-glucose co-transporter 2 inhibitor can reduce the probability of nephrolithiasis in diabetic and non-diabetic people.

Keywords: Nephrolithiasis, Renal stone, SGLT2 inhibitors, Sodium-glucose co-transporter 2 inhibitors, Type 2 diabetes